Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases
Open accessThe DOI matches its Crossref record; 95 of the 96 references it cites were found in a registry or an index.
Abstract
There is a rising interest in use of big data approaches to personalize treatment of inflammatory bowel diseases (IBDs) and to predict and prevent outcomes such as disease flares and therapeutic nonresponse. Machine learning (ML) provides an avenue to identify and quantify features across vast quantities of data to produce novel insights in disease management. In this review, we cover current approaches in ML-driven predictive outcomes modeling for IBD and relate how advances in other fields of medicine may be applied to improve future IBD predictive models. Numerous studies have incorporated clinical, laboratory, or omics data to predict significant outcomes in IBD, including hospitalizations, outpatient corticosteroid use, biologic response, and refractory disease after colectomy, among others, with considerable health care dollars saved as a result. Encouraging results in other fields of medicine support efforts to use ML image analysis—including analysis of histopathology, endoscopy, and radiology—to further advance outcome predictions in IBD. Though obstacles to clinical implementation include technical barriers, bias within data sets, and incongruence between limited data sets preventing model validation in larger cohorts, ML-predictive analytics have the potential to transform the clinical management of IBD. Future directions include the development of models that synthesize all aforementioned approaches to produce more robust predictive metrics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A significant challenge arises when many ML models intended for clinical use potentially fall under FDA/EMA regulations as medical devices or clinical decision support software.110,111”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
Cortes, C., & Vapnik, V. (1995) · Machine-mediated learning · doi:10.1023/a:1022627411411 · Cited by 48,445
Wold, S., Esbensen, K., & Geladi, P. (1987) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/0169-7439(87)80084-9 · Cited by 11,606
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450
The use of the area under the ROC curve in the evaluation of machine learning algorithms
Bradley, A. P. (1997) · Pattern Recognition · doi:10.1016/s0031-3203(96)00142-2 · Cited by 7,217
A guide to deep learning in healthcare
Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., Cui, C., Corrado, G., Thrun, S., & Dean, J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0316-z · Cited by 5,312
Rajkomar, A., Dean, J., & Kohane, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1814259 · Cited by 4,579
The global k-means clustering algorithm
Likas, A., Vlassis, N., & J. Verbeek, J. (2003) · Pattern Recognition · doi:10.1016/s0031-3203(02)00060-2 · Cited by 3,733
Cited by
Gui, X., Bazarova, A., del Amor, R., Vieth, M., de Hertogh, G., Villanacci, V., Zardo, D., Parigi, T. L., Røyset, E. S., Shivaji, U. N., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326376 · Cited by 136
Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives
Yang, X., Guo, H., & Zou, M. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00395-z · Cited by 92
“AI-assisted endoscopic image analysis and histopathological slide evaluation have markedly enhanced the objectivity of activity assessment and the accuracy of relapse-risk prediction [570, 571].”
Iacucci, M., Santacroce, G., Zammarchi, I., Maeda, Y., Del Amor, R., Meseguer, P., Kolawole, B. B., Chaudhari, U., Di Sabatino, A., Danese, S., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00053-0 · Cited by 73
Cannarozzi, A. L., Latiano, A., Massimino, L., Bossa, F., Giuliani, F., Riva, M., Ungaro, F., Guerra, M., Brina, A. L. D., Biscaglia, G., et al. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12655 · Cited by 66
Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers
Meštrović, A., Perković, N., Božić, D., Kumrić, M., Vilović, M., & Božić, J. (2024) · Biomedicines · doi:10.3390/biomedicines12071520 · Cited by 45
“These models analyze clinical data, genetic profiles, and biomarker levels to generate personalized treatment recommendations [184,185].”
BackgroundArtificial‐intelligence‐based decision support tools for the differential diagnosis of colitis
Guimarães, P., Finkler, H., Reichert, M., Zimmer, V., Grünhage, F., Krawczyk, M. J., Lammert, F., Keller, A., & Casper, M. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.13960 · Cited by 24
Cai, W., Xu, J., Chen, Y., Wu, X. H., Zeng, Y., & Yu, F. (2023) · Inflammation · doi:10.1007/s10753-023-01827-0 · Cited by 18
Harun, R., Lu, J. J.-Q., Kassir, N., & Zhang, W. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3076 · Cited by 17
“7 for a recent review).”
Artificial Intelligence in Endoscopic and Ultrasound Imaging for Inflammatory Bowel Disease
Crăciun, R., Bumbu, A. L., Ichim, V. A., Tanțău, A. I., & Tefas, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124291 · Cited by 14
Grassi, G., Laino, M. E., Fantini, M. C., Argiolas, G. M., Cherchi, M. V., Nicola, R., Gerosa, C., Cerrone, G., Mannelli, L., Balestrieri, A., et al. (2022) · European Journal of Radiology · doi:10.1016/j.ejrad.2022.110551 · Cited by 12
Artificial intelligence: A new tool in the pathologist's armamentarium for the diagnosis of IBD
Cannarozzi, A. L., Massimino, L., Latiano, A., Parigi, T. L., Giuliani, F., Bossa, F., Brina, A. L. D., Ungaro, F., Biscaglia, G., Danese, S., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.09.003 · Cited by 12
“Imaging techniques applied to pathologies other than IBD, particularly in the field of oncology [12], have brought numerous advantages in terms of accuracy, precision, and speed of examination, generating interest in the histological analysis of gastrointestinal inflammation [13].”
Okpete, U. E., & Byeon, H. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i35.111033 · Cited by 9
“These models can predict significant outcomes such as hospitalizations and treatment response, potentially reducing healthcare costs[33].”
Shephard, J. L. V., Robles, E. J. A., Hijón, C. C., Hernández‐Breijo, B., Novella-Navarro, M., Bogas, P., de la Cámara, R. C., Criado, A. B., Granados, E. L., & Rodríguez, C. P. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22925 · Cited by 10
“The arrival of this technology in rheumatology, and more specifically in rheumatoid arthritis, is already having considerable impact [25].”
BackgroundIannone, S., Kaur, A., & Johnson, K. B. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09938-0 · Cited by 19
Qi, J., Ruan, G., Liu, J., Yang, Y., Cao, Q., Wei, Y., & Nian, Y. (2022) · Bioengineering · doi:10.3390/bioengineering9110632 · Cited by 9
“Deep Learning for UC Severity Classification In recent years, deep-learning-based algorithms have replaced traditional machine learning methods due to superior recognition ability and end-to-end training strategies and have shown promise in gastroenteroscopy image diagnosis applications [26,27].”
Ou, J., Li, L., Zhi, F., Huang, B., & Zhao, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1530508 · Cited by 7
Artificial intelligence in inflammatory bowel disease: Current applications and future directions
Minea, H. O., Sîngeap, A.-M., Minea, M., Chiriac, S. A., Stanciu, C., & Trifan, A. V. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i39.111353 · Cited by 8
“…provided by operators, and the application of DL that involves the use of complex algorithms, such as artificial neural networks or convolutional neural network (CNN), designed to establish statistical associations between variables used to adjust behaviors and establish predictions[11-13].”
Dahiya, D. S., Ali, H., Moond, V., Shah, M. D. A., Santana, C., Ali, N., Sheikh, A. B., Nadeem, M., Munir, A., Quazi, M. A., et al. (2025) · Gastroenterology Research · doi:10.14740/gr2011 · Cited by 6
“Machine learning models are being developed to predict disease flares in conditions such as inflammatory bowel disease, aiding in early intervention and customized treatment plans [15].”
Tariq, R., Sethi, A., Arunachalam, S. P., Pardi, D. S., Faubion, W. A., & Khanna, S. (2026) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003922 · Cited by 5
Kedari, N., Dey, U., Sreenija, D., Paul, S., Shakya, S., Biswas, R., Ramaiah, S., & Anbarasu, A. (2026) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2026.100452 · Cited by 4
Kuenzig, M. E., Walters, T. D., Mack, D. R., Griffiths, A. M., Duchen, R., Bernstein, C. N., Kaplan, G. G., Otley, A. R., El‐Matary, W., Yu, W., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae148 · Cited by 4
Huang, L., Lin, B., Mu, Y., Ren, Y., Li, Q., Li, Y., Ma, Y., Fan, Y., Zhu, G., Song, Z., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02062-3 · Cited by 3
Pinton, P. (2024) · Diagnostics · doi:10.3390/diagnostics14131324 · Cited by 3
“Remarkably, patients predicted to be remitters had a higher probability of achieving corticosteroid-free endoscopic remission [11].”
BackgroundUltrastructural changes in chronic inflammatory enteropathies—a comparison between dogs and humans
Fietz, S. A., Kalusa, M., Jergens, A. E., Sahoo, D. K., Stewart, T., & Heilmann, R. M. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1379714 · Cited by 3
Dong, R., Wang, Y., Yao, H., Chen, T., Zhou, Q., Zhao, B., & Xu, J. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s378069 · Cited by 2
Novel Image Processing Technique for Detection of Brain Inflammatory Diseases Using MRI Images
Younes, R., Sidani, M. M. E., Kehdi, W., Yaacoub, C., Jreije, M., & Daou, R. A. Z. (2023) · International Conference on Advances in Biomedical Engineering (ICABME) · doi:10.1109/icabme59496.2023.10293009 · Cited by 2
Assessing endoscopic remission in small bowel Crohn's disease: Are markers enough?
Issa, I. A., & Issa, T. (2025) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v17.i4.106083 · Cited by 2
Mohan, A., Ghaffar, U., Basharat, A., Nawaz, G., Khenhrani, R. R., Rimsha, Vera, G. D. J. A., Lal, P. M., Tanush, D., Khan, M. K., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003633 · Cited by 1
“Additionally, IVIg infusion may suppress pathogenic cytokines, modulate B and T cell responses, neutralize harmful autoantibodies, and disrupt complement aggregation at target tissues [ 71 , 72 ] .”
Rodríguez, J. L. G., Parrado, C. V., Ramos, J., Bouallou, A., de la Hoz, M. Á. A., & Argüelles‐Arias, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-25370-0 · Cited by 1
Seify, M., Moghaddam, M. J., Sarwar, D., Hansani, W. K., Thiwanthika, K. P. D. Y. M., Frahmand, A., Osadugba, T., Dang, T. D., Ghashami, H., & Far, A. H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40379-8.00009-0 · Cited by 1
Zhang, Y., Zhao, Q., Miao, J., Tu, J., Wang, P., Li, A., & Li, J. N. (2026) · Medicine · doi:10.1097/md.0000000000048832 · Cited by 1
“[10,11] Serum GSN levels demonstrate inverse correlation with disease activity, with significant reductions observed during active inflammation compared to remission states.”
InfluentialAnalysis of Alternative Splicing Events in Melanoma and the Implications for Prognosis
Deng, H., Huang, X. L., Zhang, J., Xu, X., Wang, J., Liu, L., Yu, Y., Feng, J., & He, Y. (2025) · Current Molecular Medicine · doi:10.2174/0115665240355992250311071633
Bao, M., Liu, W., Shi, H., Meng, M., & Cao, J. (2025) · Gastroenterology Research and Practice · doi:10.1155/grp/1506567
Metagenomics - AI powered prediction of Inflammatory Bowel’s Disease and Probiotic RecommendationPreprint
Kumar, S. N., Thomas, M., Chinnakanu, S. J., Melethadathil, N., & Subramaniam, S. (2026) · medRxiv · doi:10.64898/2026.02.12.26345333
Personalized medicine in gastroenterology
Khan, H. R., Junaid, K., Muhammad, N., Tariq, A., Slahuddin, & Yasmeen, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00035-2
Kong, Y., Cui, C., Zhu, A., Zhang, T., Ye, X., Zhang, W., Tang, Y., & Wu, J. (2026) · BMC Pediatrics · doi:10.1186/s12887-026-06891-7
“In IBD, many ML methods have successfully predicted important disease outcomes, including hospitalization, steroid use, biological response and refractory diseases after colectomy [9].”
Noble, O., Pasupuleti, P., Shehadeh, F., Reddy, D., Sweeney, C., Bara, R., Lewis, M., Quigley, E. M. M., Abraham, B. P., & Fan, C. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-10180-9
Bouhddi, G., Rapp, E., Artiemjew, P., Berset, I. P., Lerang, F., Hoff, D. A. L., Bækkevold, E. S., Lundin, K. E. A., Jahnsen, F. L., & Domańska, D. (2026) · medRxiv · doi:10.64898/2026.10.05.26364793
Chamchoum, E., Chamchoum, N., khouzami, K., Ghaleb, J., Ghaleb, N., Kfoury, K., Tayoun, N., RIZK, R. B., Karam, K. S., Hallak, M., et al. (2026) · Sage Open Pathology · doi:10.1177/30502098261502319
Metadata
- Authors
- Javaid, A., Shahab, O., Adorno, W., Fernandes, P., May, E., & Syed, S.
- Affiliations
- University of Virginia (US)
- Virginia Commonwealth University (US)
- Children's National (US)
- Corresponding author
- Syed, Sana
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-08-21
- Volume
- 28
- Issue
- 6
- Pages
- 819-829
- ISSN
- 1078-0998 (ISSN-L)
- 1536-4844
- PMC
- PMC9165557
- OpenAlex
- W3195179678
- Cited by
- 36
- References
- 96
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 7 · 2023: 5 · 2022: 3
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK117061-01A1)
- National Institutes of Health
- Litwin IBD Pioneers program
- Crohn’s & Colitis Foundation
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
- Keywords
- machine learning, predictive modeling
- MeSH terms
- Machine Learning, Hospitalization, Humans, Prognosis, Inflammatory Bowel Diseases, Bias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.